Barclays Maintains Overweight on Zurn Elkay Water Solns, Lowers Price Target to $56
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst William Grippin maintains Zurn Elkay Water Solns (NYSE:ZWS) with a Overweight and lowers the price target from $61 to $56.
Barclays analyst William Grippin maintains Zurn Elkay Water Solns (NYSE:ZWS) with a Overweight and lowers the price target from $61 to $56.
